Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.

Advances in cancer research - 1 Jan 2025

Yildirim Onur, Young Robert J

Abstract excerpt

Advancements in imaging techniques and analyses have evolved in parallel with advancements in precision oncology and the transformative changes in glioma diagnosis and management. This chapter explores the pivotal roles of modern qualitative and quantitative imaging in characterizing gliomas, particularly low-grade gliomas (LGGs). Key topics include the integration of standard imaging biomarkers (e.g., T2-FLAIR...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease Management
Share to Glioma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Precision Medicine

Source

Identifiers

PMID: 40675689
DOI: 10.1016/bs.acr.2025.05.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advanced imaging of IDH-mutant gliomas: Precision in diagnosis and management.PMID 40675689Read ↗

Advances in molecular and imaging biomarkers in lower-grade gliomas.Semantic proximity Read ↗

Imaging biomarkers for detecting IDH mutations and monitoring response to novel targeted therapies: Current insights and future perspectives.Semantic proximity Read ↗

Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.Semantic proximity Read ↗

The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study.Semantic proximity Read ↗

Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusSemantic proximity Read ↗

Imaging prediction of isocitrate dehydrogenase (IDH) mutation in patients with glioma: a systemic review and meta-analysis.Semantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomasSemantic proximity Read ↗

Imaging Findings of New Entities and Patterns in Brain Tumor: Isocitrate Dehydrogenase Mutant, Isocitrate Dehydrogenase Wild-Type, Codeletion, and MGMT Methylation.Semantic proximity Read ↗

Identification of T2W hypointense ring as a novel noninvasive indicator for glioma grade and IDH genotype.Semantic proximity Read ↗

Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Semantic proximity Read ↗

Diagnostic Approaches to Adult-Type Diffuse Glial Tumors: Comparative Literature and Clinical Practice Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.